Discovery of pyrrolo-benzo-1,4-diazines as potent Nav1.7 sodium channel blockers

被引：11
|
作者：
Ho, Ginny D. [1 ]
Tulshian, Deen [1 ]
Bercovici, Ana [1 ]
Tan, Zheng [1 ]
Hanisak, Jennifer [1 ]
Brumfield, Stephanie [1 ]
Matasi, Julius [1 ]
Heap, Charles R. [2 ]
Earley, William G. [2 ]
Courneya, Brandy [2 ]
Herr, R. Jason [2 ]
Zhou, Xiaoping [3 ]
Bridal, Terry [4 ]
Rindgen, Diane [5 ]
Sorota, Steve [4 ]
Yang, Shu-Wei [1 ]
机构：
[1] Merck Res Lab, Discovery Chem, Kenilworth, NJ 07033 USA
[2] AMRI Global, Dept Med Chem, Albany, NY 12203 USA
[3] Merck Res Lab, In Vivo Pharmacol Grp, Kenilworth, NJ 07033 USA
[4] Merck Res Lab, Cardiorenal Grp, Kenilworth, NJ 07033 USA
[5] Merck Res Lab, Pharmacokinet Pharmacodynam & Drug Metab, Kenilworth, NJ 07033 USA
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2014年 / 24卷 / 17期
关键词：
Nav1.7; Nav1.5; Pain; Sodium channel blockers; Pyrrolo-benzo-1,4-diazine; PAIN; GENES; EXPRESSION; NEURONS;
D O I：
10.1016/j.bmcl.2014.07.060
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
A series of pyrrolo-benzo-1,4-diazine analogs have been synthesized and displayed potent Na(v)1.7 inhibitory activity and moderate selectivity over Na(v)1.5. The syntheses, structure-activity relationships, and selected pharmacokinetic data of these analogs are described. Compound 41 displayed anti-nociceptive efficacy in the rat CFA pain model at 100 mpk oral dosing. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码：4110 / 4113
页数：4
相关论文
共 50 条
  • [21] Compound heterozygosity in sodium channel Nav1.7 in a family with hereditary erythermalgia
    Samuels, Mark E.
    Morsche, Rene H. M. te
    Lynch, Mary E.
    Drenth, Joost P. H.
    MOLECULAR PAIN, 2008, 4
  • [22] Discovery of a novel class of benzazepinone Nav1.7 blockers:: Potential treatments for neuropathic pain
    Hoyt, Scott B.
    London, Clare
    Gorin, David
    Wyvratt, Matthew J.
    Fisher, Michael H.
    Abbadie, Catherine
    Felix, John P.
    Garcia, Maria L.
    Li, Xiaohua
    Lyons, Kathryn A.
    McGowan, Erin
    MacIntyre, D. Euan
    Martin, William J.
    Priest, Birgit T.
    Ritter, Amy
    Smith, McHardy M.
    Warren, Vivien A.
    Williams, Brande S.
    Kaczorowski, Gregory J.
    Parsons, William H.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (16) : 4630 - 4634
  • [23] Phenethyl nicotinamides, a novel class of NaV1.7 channel blockers: Structure and activity relationship
    Kers, Inger
    Macsari, Istvan
    Csjernyik, Gabor
    Nylof, Martin
    Skogholm, Karin
    Sandberg, Lars
    Minidis, Alexander
    Bueters, Tjerk
    Malmborg, Jonas
    Eriksson, Anders B.
    Lund, Per-Eric
    Venyike, Elisabet
    Luo, Lei
    Nystrom, Jan-Erik
    Besidski, Yevgeni
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (19) : 6108 - 6115
  • [24] Naphthylisoquinoline alkaloids, a new structural template inhibitor of Nav1.7 sodium channel
    Wang, Qiao-qiao
    Wang, Long
    Zhang, Wen-bo
    Tang, Chun-ping
    Chen, Xue-qin
    Zheng, Yue-ming
    Yao, Sheng
    Gao, Zhao-bing
    Ye, Yang
    ACTA PHARMACOLOGICA SINICA, 2023, 44 (9) : 1768 - 1776
  • [25] Mechanism of inhibition by chlorpromazine of the human pain threshold sodium channel, Nav1.7
    Lee, Su-Jin
    Kim, Dong-Hyun
    Hahn, Sang June
    Waxman, Stephen G.
    Choi, Jin-Sung
    NEUROSCIENCE LETTERS, 2017, 639 : 1 - 7
  • [26] The voltage-gated sodium channel Nav1.7 associated with endometrial cancer
    Liu, Junxiu
    Tan, Hao
    Yang, Wancai
    Yao, Shuzhong
    Hong, Liang
    JOURNAL OF CANCER, 2019, 10 (20): : 4954 - 4960
  • [27] Computational design of binders targeting the VSDIV from NaV1.7 sodium channel
    Mateos, Diego Lopez
    Murray, Adam M.
    Nguyen, Hai M.
    Venkatesh, Preetham
    Koepnick, Brian
    Baker, David
    Wulff, Heike
    Yarov-Yarovoy, Vladimir
    BIOPHYSICAL JOURNAL, 2024, 123 (03) : 108A - 108A
  • [28] OSTEOARTHRITIS-DEPENDENT CHANGES IN ANTINOCICEPTIVE ACTION OF NAV1.7 AND NAV1.8 SODIUM CHANNEL BLOCKERS: AN IN VIVO ELECTROPHYSIOLOGICAL STUDY IN THE RAT
    Rahman, W.
    Dickenson, A. H.
    NEUROSCIENCE, 2015, 295 : 103 - 116
  • [29] Loss-of-function mutations in sodium channel Nav1.7 cause anosmia
    Weiss, Jan
    Pyrski, Martina
    Jacobi, Eric
    Bufe, Bernd
    Willnecker, Vivienne
    Schick, Bernhard
    Zizzari, Philippe
    Gossage, Samuel J.
    Greer, Charles A.
    Leinders-Zufall, Trese
    Woods, C. Geoffrey
    Wood, John N.
    Zufall, Frank
    NATURE, 2011, 472 (7342) : 186 - 190
  • [30] Naphthylisoquinoline alkaloids, a new structural template inhibitor of Nav1.7 sodium channel
    Qiao-qiao Wang
    Long Wang
    Wen-bo Zhang
    Chun-ping Tang
    Xue-qin Chen
    Yue-ming Zheng
    Sheng Yao
    Zhao-bing Gao
    Yang Ye
    Acta Pharmacologica Sinica, 2023, 44 : 1768 - 1776
12345